Columbia Research Enhanced Core ETF (RECS) Chart & Stock Price History → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free RECS Stock Alerts $29.85 -0.27 (-0.90%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Columbia Research Enhanced Core ETF Stock Price Performance5 Day Performance+1.26%1 Month Performance-3.12%3 Month Performance+4.19%6 Month Performance+21.19%Year-To-Date Performance+7.72%1 Year Performance+24.53% Receive RECS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Columbia Research Enhanced Core ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. RECS Stock Chart for Thursday, April, 25, 2024 RECS Chart by TradingView Columbia Research Enhanced Core ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024$30.08$29.85-0.76%$29.91$29.5272,462 shs$435.81 million04/24/2024$30.11$30.08-0.10%$30.24$29.97102,224 shs$439.17 million04/23/2024$29.80$30.11+1.04%$30.19$29.8984,990 shs$439.61 million04/22/2024$29.48$29.80+1.09%$29.98$29.5570,151 shs$435.08 million04/19/2024$29.73$29.48-0.84%$29.73$29.4188,349 shs$430.41 million04/18/2024$29.71$29.73+0.07%$29.95$29.66107,893 shs$434.06 million Get the Latest News and Ratings for RECS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Columbia Research Enhanced Core ETF and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024$29.92$29.71-0.70%$30.07$29.66167,770 shs$433.77 million04/16/2024$30.02$29.92-0.33%$30.05$29.8470,095 shs$436.83 million04/15/2024$30.37$30.02-1.15%$30.68$29.97581,203 shs$438.29 million04/12/2024$30.85$30.37-1.56%$30.68$30.29200,935 shs$443.40 million04/11/2024$30.62$30.85+0.75%$30.89$30.4465,655 shs$283.82 million04/10/2024$30.73$30.62-0.36%$30.68$30.47257,910 shs$281.70 million04/09/2024$30.82$30.73-0.29%$30.92$30.5881,046 shs$282.72 million04/08/2024$30.81$30.82+0.03%$30.91$30.7832,223 shs$283.54 million04/05/2024$30.44$30.81+1.22%$30.96$30.5058,868 shs$283.45 million04/04/2024$30.84$30.44-1.30%$31.09$30.4471,342 shs$280.05 million04/03/2024$30.76$30.84+0.26%$30.94$30.7460,815 shs$283.73 million04/02/2024$30.96$30.76-0.65%$30.81$30.6771,213 shs$282.99 million04/01/2024$30.98$30.96-0.06%$31.10$30.8578,618 shs$284.83 million03/29/2024$30.98$30.98$31.06$30.9370,190 shs$285.02 million03/28/2024$30.91$30.98+0.23%$31.06$30.9370,190 shs$285.02 million03/27/2024$30.84$30.91+0.23%$30.97$30.7373,952 shs$284.37 million03/26/2024$30.81$30.84+0.10%$30.86$30.6865,353 shs$283.73 million03/25/2024$30.80$30.81+0.03%$30.84$30.74207,052 shs$283.45 million03/22/2024$30.86$30.80-0.19%$30.90$30.8031,626 shs$283.36 million03/21/2024$30.72$30.86+0.46%$30.97$30.8685,733 shs$283.91 million03/20/2024$30.51$30.72+0.69%$30.80$30.4357,088 shs$282.62 million03/19/2024$30.27$30.51+0.79%$30.52$30.2471,264 shs$280.69 million03/18/2024$30.14$30.27+0.43%$30.46$30.2747,749 shs$278.48 million03/15/2024$30.37$30.14-0.76%$30.22$30.0276,963 shs$277.29 million03/14/2024$30.42$30.37-0.16%$30.47$30.1942,336 shs$279.40 million03/13/2024$30.32$30.42+0.33%$30.46$30.3352,796 shs$279.86 million03/12/2024$30.06$30.32+0.86%$30.41$30.0796,421 shs$278.94 million03/11/2024$30.07$30.06-0.03%$30.07$29.86117,109 shs$276.55 million03/08/2024$30.18$30.07-0.36%$30.44$30.03135,918 shs$276.64 million03/07/2024$29.90$30.18+0.94%$30.24$30.0462,320 shs$277.66 million03/06/2024$29.77$29.90+0.44%$30.03$29.79104,086 shs$275.08 million03/05/2024$30.05$29.77-0.93%$29.93$29.62237,001 shs$273.88 million03/04/2024$30.05$30.05$30.15$29.9870,695 shs$276.46 million03/01/2024$29.86$30.05+0.64%$30.12$29.9064,138 shs$276.46 millionThe World's First "$20 Trillion Drug?" (Ad)One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>>02/29/2024$29.75$29.86+0.37%$29.99$29.68237,417 shs$274.71 million02/28/2024$29.82$29.75-0.23%$29.79$29.6768,724 shs$273.70 million02/27/2024$29.71$29.82+0.37%$29.82$29.62160,378 shs$274.34 million02/26/2024$29.87$29.71-0.54%$29.87$29.71346,130 shs$273.33 million02/23/2024$29.83$29.87+0.13%$30.01$29.8250,465 shs$274.80 million02/22/2024$29.20$29.83+2.16%$29.88$29.5477,722 shs$274.44 million02/21/2024$29.12$29.20+0.27%$29.20$28.98152,920 shs$268.64 million02/20/2024$29.25$29.12-0.44%$29.18$29.0258,924 shs$267.90 million02/19/2024$29.25$29.25$29.49$29.2571,500 shs$269.10 million02/16/2024$29.45$29.28-0.58%$29.49$29.2571,574 shs$269.38 million02/15/2024$29.35$29.45+0.34%$29.46$29.27397,189 shs$270.94 million02/14/2024$29.06$29.35+1.00%$29.35$28.9975,514 shs$270.02 million02/13/2024$29.44$29.06-1.29%$29.13$28.82103,087 shs$267.35 million02/12/2024$29.47$29.44-0.10%$29.59$29.3984,967 shs$270.85 million02/09/2024$29.27$29.47+0.68%$29.48$29.2544,296 shs$271.12 million02/08/2024$29.28$29.27-0.03%$29.27$29.161.19 million shs$269.28 million02/07/2024$29.03$29.28+0.86%$29.30$29.12131,875 shs$269.38 million02/06/2024$28.96$29.03+0.24%$29.08$28.93138,485 shs$267.08 million02/05/2024$29.12$28.96-0.55%$29.10$28.8487,743 shs$266.43 million02/02/2024$28.67$29.12+1.57%$29.21$28.81221,035 shs$267.90 million02/01/2024$28.38$28.67+1.02%$28.70$28.42212,660 shs$263.76 million01/31/2024$28.88$28.38-1.73%$28.78$28.3457,870 shs$261.10 million01/30/2024$28.89$28.88-0.03%$28.91$28.7726,659 shs$265.70 million01/29/2024$28.64$28.89+0.87%$28.89$28.5940,691 shs$265.79 million01/26/2024$28.65$28.64-0.03%$28.75$28.57802,013 shs$263.49 million01/25/2024$28.39$28.65+0.92%$28.65$28.5197,803 shs$263.58 million01/24/2024$28.39$28.39$28.63$28.38326,722 shs$261.19 million Related Companies: VictoryShares US 500 Enhanced Volatility Wtd ETF Stock Price Chart Fidelity Low Volatility Factor ETF Stock Price Chart Putnam Focused Large Cap Value ETF Stock Price Chart Gotham Enhanced 500 ETF Stock Price Chart Hartford Multifactor US Equity ETF Stock Price Chart AllianzIM U.S. Large Cap Buffer20 Jan ETF Stock Price Chart ProShares Ultra Dow30 Stock Price Chart Strive 500 ETF Stock Price Chart JPMorgan Hedged Equity Laddered Overlay ETF Stock Price Chart Fidelity Value Factor ETF Stock Price Chart Receive RECS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Columbia Research Enhanced Core ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:RECS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Columbia Research Enhanced Core ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.